IMMUNOHISTOCHEMISTRY HER-2 ERBB2 BREAST Test
Cost: AED 370.0
Test Name: IMMUNOHISTOCHEMISTRY HER-2 ERBB2 BREAST Test
Components: Price: 370.0 AED
Sample Condition: Submit tumor tissue in 10% Formal-saline OR Formalin fixed paraffin embedded block. Ship at room temperature. Provide a copy of the Histopathology report, Site of biopsy and Clinical history.
Report Delivery: Sample Daily by 6 pm; Report Block: 5 days, Tissue Biopsy: 5 days, Tissue large complex: 7 days
Method: Immunohistochemistry
Test type: Cancer
Doctor: Oncologist, Pathologist
Test Department:
Pre Test Information: Provide a copy of the Histopathology report, Site of biopsy and Clinical history.
Test Details
The IMMUNOHISTOCHEMISTRY HER-2/ERBB2 (BREAST) test is a diagnostic test used in breast cancer patients to determine the presence and level of the HER-2 protein in tumor cells. HER-2, also known as ERBB2, is a receptor protein that plays a role in cell growth and division.
This test involves the use of specific antibodies that bind to the HER-2 protein in breast cancer tissue samples. The antibodies are labeled with a visible marker, such as a fluorescent dye or an enzyme, which allows the detection of the protein in the tissue.
The results of the test are usually reported as a score based on the staining intensity and the percentage of tumor cells showing HER-2 protein expression. The scoring system ranges from 0 to 3+, with 0 or 1+ indicating low or no HER-2 expression, 2+ indicating equivocal expression, and 3+ indicating high expression.
The IMMUNOHISTOCHEMISTRY HER-2/ERBB2 test is important in determining the eligibility of breast cancer patients for targeted therapy with drugs like trastuzumab (Herceptin). High levels of HER-2 expression indicate a higher likelihood of response to these targeted therapies.
It is important to note that this test is typically performed on breast cancer tissue samples obtained through a biopsy or surgery. It is usually ordered by a pathologist or an oncologist as part of the diagnostic workup for breast cancer patients.
Test Name | IMMUNOHISTOCHEMISTRY HER-2 ERBB2 BREAST Test |
---|---|
Components | |
Price | 370.0 AED |
Sample Condition | Submit tumor tissue in 10% Formal-saline OR Formalin fixed paraffin embedded block. Ship at room temperature. Provide a copy of the Histopathology report, Site of biopsy and Clinical history. |
Report Delivery | Sample Daily by 6 pm; Report Block: 5 days Tissue Biopsy: 5 days Tissue large complex : 7 days |
Method | Immunohistochemistry |
Test type | Cancer |
Doctor | Oncologist, Pathologist |
Test Department: | |
Pre Test Information | Provide a copy of the Histopathology report, Site of biopsy and Clinical history. |
Test Details | The IMMUNOHISTOCHEMISTRY HER-2/ERBB2 (BREAST) test is a diagnostic test used in breast cancer patients to determine the presence and level of the HER-2 protein in tumor cells. HER-2, also known as ERBB2, is a receptor protein that plays a role in cell growth and division. This test involves the use of specific antibodies that bind to the HER-2 protein in breast cancer tissue samples. The antibodies are labeled with a visible marker, such as a fluorescent dye or an enzyme, which allows the detection of the protein in the tissue. The results of the test are usually reported as a score based on the staining intensity and the percentage of tumor cells showing HER-2 protein expression. The scoring system ranges from 0 to 3+, with 0 or 1+ indicating low or no HER-2 expression, 2+ indicating equivocal expression, and 3+ indicating high expression. The IMMUNOHISTOCHEMISTRY HER-2/ERBB2 test is important in determining the eligibility of breast cancer patients for targeted therapy with drugs like trastuzumab (Herceptin). High levels of HER-2 expression indicate a higher likelihood of response to these targeted therapies. It is important to note that this test is typically performed on breast cancer tissue samples obtained through a biopsy or surgery. It is usually ordered by a pathologist or an oncologist as part of the diagnostic workup for breast cancer patients. |